Results 61 to 70 of about 168,585 (146)

Nanomicellar Prodrug Delivery of Glucose-Paclitaxel: A Strategy to Mitigate Paclitaxel Toxicity

open access: yesInternational Journal of Nanomedicine
Didi Yan,1 Xinyue Ma,1 Yixin Hu,1 Guogang Zhang,1 Beibei Hu,1 Bo Xiang,2 Xiaokun Cheng,1,3 Yongshuai Jing,1 Xi Chen1,4 1College of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, 050018, People’s ...
Yan D   +8 more
doaj  

Progesterone Is Associated With Increased Vasohibin-2 Expression, Tubulin Detyrosination, and Paclitaxel Sensitivity in PR-Negative Ovarian Cancer Cells. [PDF]

open access: yesCancer Rep (Hoboken)
Koyanagi T   +9 more
europepmc   +1 more source

DHX9 Inhibition Enhances Paclitaxel Sensitivity by Inducing Mitotic Failure in Ovarian and Endometrial Cancers. [PDF]

open access: yesMol Cancer Ther
Huang TT   +7 more
europepmc   +1 more source

Proteomic Adaptations in the Spinal Cord of a Breast Cancer Model of Paclitaxel-Induced Peripheral Neuropathy. [PDF]

open access: yesJ Proteome Res
Schwarting SP   +9 more
europepmc   +1 more source

Umbralisib antagonizes multidrug resistance in ABCB1-overexpressing cancer cells. [PDF]

open access: yesFront Oncol
Bo L   +9 more
europepmc   +1 more source

Dioscin Reverses Drug Resistance via AKT/GSK3β-mediated P-gp Degradation and EMT Inhibition. [PDF]

open access: yesDrug Dev Res
Zhang K   +10 more
europepmc   +1 more source

Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer. [PDF]

open access: yesClin Cancer Res
Schmid P   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy